Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation
Background: ABO-incompatible (ABOi) kidney transplantation can be achieved by desensitizing the recipient using apheresis plus rituximab-based immunosuppression. Objectives: We sought to ascertain the factors that contributed to low immunoglobulin levels at post-ABOi kidney transplantation. Patients...
Saved in:
Main Authors: | Hamza Naciri Bennani (Author), Zhyiar Abdulraham (Author), Bénédicte Puissant-Lubrano (Author), Asma Allal (Author), Lionel Rostaing (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early post-transplant complications following ABO-incompatible kidney transplantation
by: Hamza Naciri Bennani, et al.
Published: (2016) -
Long-term outcomes after ABO-incompatible kidney transplantation; a single-center French study
by: Zhiyar Abdulrahman, et al.
Published: (2017) -
Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates
by: Lionel Rostaing, et al.
Published: (2016) -
Current Perspectives in ABO-Incompatible Kidney Transplant
by: Maritati F, et al.
Published: (2022) -
Current progress in ABO-incompatible kidney transplantation
by: Tai Yeon Koo, et al.
Published: (2015)